Discover the complete record of transactions filed by Vig Pamela, Directeur Scientifique. Officer active across 1 companies, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 9 reports have been recorded. The latest transaction was disclosed on 10 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Pamela Vig is the Chief Scientific Officer and Head of Research & Development at Mirum Pharmaceuticals, Inc. She is responsible for the company's research and development strategy. Her scientific expertise is essential for innovation and the development of new products.